基于受体结构的AHAS抑制剂的设计、合成及生物活性

在AHAS与磺酰脲类除草剂复合物的晶体结构基础上, 利用分子对接程序DOCK 4.0, 通过MDL/ACD三维数据库虚拟筛选, 得到了296个与AHAS结合能较低的小分子化合物结构信息, 从中选取了部分小分子进行化学合成, 并且测试了其生物活性. 部分化合物的体内和体外活性表现出一定的一致性.     

Determination of low level nitrite and nitrate in biological, food and environmental samples by gas chromatography-mass spectrometry and liquid chromatography with fluorescence detection

Gas chromatography-mass spectrometry (GC-MS) and liquid chromatography with fluorescence detection (LC-FL) methods have been proposed for the determination of low level nitrite and nitrate in biological, food and environmental samples. The methods include derivatization of aqueous nitrite with 2,3-diaminonaphthalene (DAN), enzymatic reduction of nitrate to nitrite, extraction with toluene and chromatographic analyses of highly fluorescent 2,3-naphthotriazole (NAT) derivative of nitrite by using GC-MS in selected-ion-monitoring (SIM) mode and LC-FL. Nitrite and nitrate ions in solid samples were extracted with 0.5 M aqueous NaOH by sonication. The recoveries of nitrite and nitrate ions based on GC-MS and LC-FL results were 98.40% and 98.10% and the precision of these methods, as indicated by the relative standard deviations (RSDs) were 1.00% for nitrite and 1.20% for nitrate, respectively. The limits of detection of the GC-MS in SIM mode and LC-FL methods based on S/N = 3 were 0.02 and 0.29 pg/ml for nitrite and 0.03 and 0.30 pg/ml for nitrate, respectively.     

天然纤维预处理技术研究进展

天然纤维预处理是影响天然纤维强化生物复合材料的关键因素。文章首先从天然纤维的物理特性、化学成分和吸湿特性三方面对纤维性能进行了陈述,针对这些性能综述了国内外常用的天然纤维预处理方法,重点介绍了碱化处理、硅烷处理、高锰酸盐处理和过氧化物处理等化学方法,并对比了天然纤维经常用化学改性方法处理后产生的结果;其次介绍了机械加工...     

含嘧啶环的1,3,4-噁二唑Mannich碱的合成及生物活性

以芳香酸为原料, 通过酯化、 肼解及环化反应制得中间体5-芳基取代-1,3,4-噁二唑-2-硫酮(C1~C3), 然后中间体与甲醛和取代氨基嘧啶(D1~D5)发生Mannich反应得到一系列新型含有嘧啶环的1,3,4-噁二唑类衍生物(E1~E15). 所得目标化合物的结构经元素分析、 IR及 ¹H NMR确认. 初步的生物活性测定结果表明, 大部分目标化合物对植物病原菌有很好的抑制作用, 其中化合物E3和E8的抑菌效果优于对照药三唑酮.     

PLA/MSM缓释微球的制备及生物活性

采用膜乳化-液中干燥法制备出担载二甲基砜(MSM)的聚乳酸(PLA)微球(PLA/MSM), 并研究了膜孔径、 搅拌转速和MSM浓度对载药微球形貌、 尺寸、 载药量、 体外释放及细胞活性的影响; 采用场发射环境扫描电子显微镜(ESEM)观察微球形貌、 尺寸及分布, 用等离子体发射光谱(ICP-AES)法检测PLA/MSM微球载药量、 包封率及体外释放, 采用ESEM观察微球内部结构, 并通过体外细胞培养和噻唑蓝(MTT)法检测MC-3T3-E1细胞的增殖能力. 研究结果表明, 膜乳化法制备的载药微球规整, 呈典型的圆球状, 表面光滑, 内部有多孔结构. 当膜孔径为5.1 μm且搅拌转速为500 r/min时, PLA/MSM微球大小更为均一; 当体系中MSM质量分数为8.6%时, 载药量可达到77.43%. 随着膜孔径减小及药物浓度的增加, 体外释放速率加快, 但初期均无明显的突释现象, 约10 d后累积释放量达到89.2%. 细胞实验结果显示, 在膜孔径为5.1 μm且MSM质量分数为8.6%的条件下, 制备的载药微球在细胞培养7 d时表现出明显的促增殖作用.     

Electrochemical Biosensors for Detection of Biological Warfare Agents

This review discusses current development in electrochemical biosensors for detection of biological warfare agents. This could include bacteria, viruses and toxins that are aerosoled deliberately in air, food or water to spread terrorism and cause disease or death to humans, animals or plants. The rapid and unequivocal detection and identification of biological warfare agents is a major challenge for any government including military, health and other government agents. Reliable, specific characterization and identification of the microorganism from sampling location, either air, water, soil or others is required. This review will survey different types of electrochemical biosensors has been developed based on the following: i) Immunosensors ii) PCR (DNA base Sensor) iii) Bacteria or whole cell sensor and iv) Enzyme sensor. This article gives an overview of electrochemical biosensor for detection of biological warfare agents. Electrochemical biosensors have the advantages of sensitivity, selectivity, to operate in turbid media, and amenable to miniaturization. Recent developments in immunofiltration, flow injection, and flow‐through electrochemical biosensors for bacteria, viruses, and toxin detection are reviewed. The current research and development in biosensors for biological warfare agents detection is of interest to the public as well as to the defense is also discussed.     

3,6-二取代-5,6-二氢-1,2,4-三唑并[3,4-b]-1,3,4-噻二唑的合成及生物活性

以３－芳基－４－氨基－５－巯基－１,２,４－三唑为原料,在酸催化下与醛类发生分子内的Ｍａｎｎｉｃｈ反应,合成了１４个标题化合物,其结构经元素分析、ＩＲ、＾１ＨＮＭＲ和ＭＳ确证。研究了反应条件。生物活性测定结果表明,部分化合物具有较强的生物活性。     

生物材料中克伦特罗的气相色谱-质谱法测定

建立了生物材料中克伦特罗 (clenbuterol)的气相色谱 -质谱测定方法 ;大白鼠喂食克伦特罗获得阳性生物材料 ,生物材料中克伦特罗经0.01mol/L盐酸溶液提取 ,乙醚脱脂净化 ,乙酸乙酯提取后蒸发至干 ,用乙醇溶解后加样到氧化铝柱上 ,用0.01mol/L盐酸溶液洗脱 ,蒸发至干后 ,用BSTFA(双三甲基硅烷基三氟乙酰胺 ) +1 % (φ)TMCS(三甲基氯硅烷 )衍生 ,采用GC -MS进行测定 ,外标法定量 ;试验表明 ,生物材料中添加0.056×10 -6～0.54×10 -6(w)含量水平的克伦特罗 ,方法回收率在89 %～107 % ,相对标准偏差为7.3 %～16 % ,线性相关系数r为0.998,克伦特罗的检出限为2.0×10-9(w)。     

吡咯聚合调控脉冲电沉积制备球形羟基磷灰石和银纳米粒子复合涂层

借助聚吡咯(PPy)的调控,采用脉冲电沉积法在生物医用金属钛表面制备出均匀的纳米HA/PPy/Ag抗菌复合涂层.考察了电解液中Py浓度、Ag~+浓度、钙磷盐浓度等对复合涂层的形貌及成分的影响.探讨了PPy聚合过程形成球形HA-NPs和Ag-NPs的形成机理,并对复合涂层的生物活性、生理稳定性及抗菌性能进行研究.研究结果表明,电解液中Py浓度的高低影响涂层的形貌,Py浓度为0.03 mol/L时有利于复合涂层的沉积.电解液中Ag~+浓度影响涂层的形貌、结晶,电解液中Ag~+浓度为0.3 mmol/L左右比较适合.电解液中Ca~(2+)浓度影响涂层的形貌及结晶,其浓度过高颗粒尺寸增大,Ca~(2+)浓度为5.0 mmol/L左右较适合.复合涂层能够诱导磷灰石的生成,使其沿着(002)晶面出现择优生长,具有较好的生物活性.PPy的加入大大降低了复合涂层中Ca~(2+)和Ag~+的释放速度,提高了复合涂层的生理稳定性.抗菌检测表明复合涂层具有良好的抗菌性.     

含吡唑环的1,2,4-三唑希夫碱类衍生物的合成及生物活性

以自制的4-氨基-4,5-二氢-3-[(3,5-二甲基吡唑-1-基)甲基]-1,2,4-三唑-5-硫酮衍生物为中间体, 与取代苯甲醛反应合成了一系列新型含吡唑环的1,2,4-三唑希夫碱衍生物. 通过红外光谱、 核磁共振波谱、 高分辨质谱、 元素分析及X射线单晶衍射对目标化合物进行了结构表征, 并初步测试了其生物活性. 结果表明, 大部分化合物表现出较好的抑菌活性, 其中化合物G9, G10和G15的抑菌效果优于对照药三唑酮.